{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:15:08Z","timestamp":1792739708413,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Brain Res"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00221-012-3101-0","type":"journal-article","created":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T11:52:35Z","timestamp":1335786755000},"page":"381-390","source":"Crossref","is-referenced-by-count":71,"title":["Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1\u03b1, and phosphorylates GSK3\u03b2 in P301L tau transgenic mice"],"prefix":"10.1007","volume":"219","author":[{"given":"J. M.","family":"Fine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Baillargeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. B.","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. S.","family":"Hoerster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tokarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Colton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pelleg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. A.","family":"Sparley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. M.","family":"Krogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,1]]},"reference":[{"issue":"1","key":"3101_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/156720507779939832","volume":"4","author":"SY Aghdam","year":"2007","unstructured":"Aghdam SY, Barger SW (2007) Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium. Curr Alzheimer Res 4(1):21\u201331","journal-title":"Curr Alzheimer Res"},{"issue":"1\u20132","key":"3101_CR2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2004.02.081","volume":"1012","author":"GW Arendash","year":"2004","unstructured":"Arendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M, Garcia MF (2004) Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer\u2019s disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res 1012(1\u20132):29\u201341","journal-title":"Brain Res"},{"issue":"5","key":"3101_CR3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.mito.2007.06.001","volume":"7","author":"H Atamna","year":"2007","unstructured":"Atamna H, Frey WH 2nd (2007) Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer\u2019s disease. Mitochondrion 7(5):297\u2013310","journal-title":"Mitochondrion"},{"issue":"4","key":"3101_CR4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2174\/156720510791162403","volume":"7","author":"Y Avramovich-Tirosh","year":"2010","unstructured":"Avramovich-Tirosh Y, Bar-Am O, Amit T, Youdim MB, Weinreb O (2010) Up-regulation of hypoxia-inducible factor (HIF) -1alpha and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30. Curr Alzheimer Res 7(4):300\u2013306","journal-title":"Curr Alzheimer Res"},{"issue":"11","key":"3101_CR5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1517\/14728222.2010.525352","volume":"14","author":"S Bandyopadhyay","year":"2010","unstructured":"Bandyopadhyay S, Huang X, Lahiri DK, Rogers JT (2010) Novel drug targets based on metallobiology of Alzheimer\u2019s disease. Expert Opin Ther Targets 14(11):1177\u20131197","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"3101_CR6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.neuroscience.2010.04.009","volume":"168","author":"J Bertrand","year":"2010","unstructured":"Bertrand J, Plouffe V, Senechal P, Leclerc N (2010) The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons. Neuroscience 168(2):323\u2013334","journal-title":"Neuroscience"},{"issue":"12","key":"3101_CR7","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1074\/jbc.M010144200","volume":"276","author":"C Chen","year":"2001","unstructured":"Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A (2001) Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem 276(12):9519\u20139525","journal-title":"J Biol Chem"},{"key":"3101_CR8","author":"S Craft","year":"2011","unstructured":"Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B (2011) Intranasal insulin therapy for Alzheimer Disease and Amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. doi: 10.1001\/archneurol.2011.233","journal-title":"Arch Neurol"},{"issue":"8753","key":"3101_CR9","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","volume":"337","author":"DR Crapper McLachlan","year":"1991","unstructured":"Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer\u2019s disease. Lancet 337(8753):1304\u20131308","journal-title":"Lancet"},{"issue":"5","key":"3101_CR10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2353\/ajpath.2009.090157","volume":"175","author":"Y Deng","year":"2009","unstructured":"Deng Y, Li B, Liu Y, Iqbal K, Grundke-Iqbal I, Gong CX (2009) Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: implication for Alzheimer\u2019s disease. Am J Pathol 175(5):2089\u20132098","journal-title":"Am J Pathol"},{"issue":"7","key":"3101_CR11","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/jps.21604","volume":"98","author":"SV Dhuria","year":"2009","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd (2009) Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system. J Pharm Sci 98(7):2501\u20132515","journal-title":"J Pharm Sci"},{"issue":"4","key":"3101_CR12","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd (2010) Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99(4):1654\u20131673","journal-title":"J Pharm Sci"},{"issue":"6","key":"3101_CR13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.devcel.2007.04.001","volume":"12","author":"BW Doble","year":"2007","unstructured":"Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR (2007) Functional redundancy of GSK-3alpha and GSK-3beta in Wnt\/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell 12(6):957\u2013971","journal-title":"Dev Cell"},{"issue":"2\u20133","key":"3101_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/JAD-2006-102-315","volume":"10","author":"JL Domingo","year":"2006","unstructured":"Domingo JL (2006) Aluminum and other metals in Alzheimer\u2019s disease: a review of potential therapy with chelating agents. J Alzheimers Dis 10(2\u20133):331\u2013341","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3101_CR15","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2353\/ajpath.2008.070097","volume":"172","author":"P Dongiovanni","year":"2008","unstructured":"Dongiovanni P, Valenti L, Ludovica Fracanzani A, Gatti S, Cairo G, Fargion S (2008) Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. Am J Pathol 172(3):738\u2013747","journal-title":"Am J Pathol"},{"issue":"3","key":"3101_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0014-5793(98)01149-1","volume":"436","author":"P Ebeling","year":"1998","unstructured":"Ebeling P, Koistinen HA, Koivisto VA (1998) Insulin-independent glucose transport regulates insulin sensitivity. FEBS Lett 436(3):301\u2013303","journal-title":"FEBS Lett"},{"issue":"1","key":"3101_CR17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-200401190-00015","volume":"15","author":"MF Garcia","year":"2004","unstructured":"Garcia MF, Gordon MN, Hutton M, Lewis J, McGowan E, Dickey CA, Morgan D, Arendash GW (2004) The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer\u2019s transgenic mice. NeuroReport 15(1):73\u201377","journal-title":"NeuroReport"},{"key":"3101_CR18","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s00125-009-1501-x","volume":"52","author":"M Hallschmid","year":"2009","unstructured":"Hallschmid M, Schultes B (2009) Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders? Diabetologia 52:2264\u20132269","journal-title":"Diabetologia"},{"issue":"4","key":"3101_CR19","first-page":"81","volume":"4","author":"LR Hanson","year":"2004","unstructured":"Hanson LR, Martinez PM, Taheri S, Kamsheh L, Mignot E, Frey WHI (2004) Intranasal administration of hypocretin 1 (Orexin A) bypasses the blood-brain barrier & targets the brain: a new strategy for the treatment of narcolepsy. Drug Deliv Technol 4(4):81\u201386","journal-title":"Drug Deliv Technol"},{"issue":"3","key":"3101_CR20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/jpet.108.149807","volume":"330","author":"LR Hanson","year":"2009","unstructured":"Hanson LR, Roeytenberg A, Martinez PM, Coppes VG, Sweet DC, Rao RJ, Marti DL, Hoekman JD, Matthews RB, Frey WH 2nd, Panter SS (2009) Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke. J Pharmacol Exp Ther 330(3):679\u2013686","journal-title":"J Pharmacol Exp Ther"},{"key":"3101_CR21","doi-asserted-by":"crossref","unstructured":"Hanson L, Fine J, Renner D, Svitak A, Burns R, Nguyen T, Tuttle N, Marti D, Panter S, Frey W (2012) Intranasal delivery of deferoxamine reduces spatial memory loss in APP\/PS1 mice. Drug Deliv Transl Res:1\u20139. doi: 10.1007\/s13346-011-0050-2","DOI":"10.1007\/s13346-011-0050-2"},{"issue":"6","key":"3101_CR22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer\u2019s disease. J Neurochem 104(6):1433\u20131439","journal-title":"J Neurochem"},{"issue":"8","key":"3101_CR23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrn2870","volume":"11","author":"EM Hur","year":"2010","unstructured":"Hur EM, Zhou FQ (2010) GSK3 signalling in neural development. Nat Rev 11(8):539\u2013551","journal-title":"Nat Rev"},{"issue":"1","key":"3101_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187221108783331429","volume":"2","author":"V Jogani","year":"2008","unstructured":"Jogani V, Jinturkar K, Vyas T, Misra A (2008) Recent patents review on intranasal administration for CNS drug delivery. Recent Pat Drug Deliv Formul 2(1):25\u201340","journal-title":"Recent Pat Drug Deliv Formul"},{"issue":"11","key":"3101_CR25","doi-asserted-by":"crossref","first-page":"e7917","DOI":"10.1371\/journal.pone.0007917","volume":"4","author":"YD Ke","year":"2009","unstructured":"Ke YD, Delerue F, Gladbach A, Gotz J, Ittner LM (2009) Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer\u2019s disease. PLoS ONE 4(11):e7917","journal-title":"PLoS ONE"},{"issue":"22","key":"3101_CR26","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.cub.2005.10.050","volume":"15","author":"X Liu","year":"2005","unstructured":"Liu X, Rubin JS, Kimmel AR (2005) Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol 15(22):1989\u20131997","journal-title":"Curr Biol"},{"issue":"1\u20132","key":"3101_CR27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","volume":"20","author":"JJ Lucas","year":"2001","unstructured":"Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20(1\u20132):27\u201339","journal-title":"EMBO J"},{"key":"3101_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","volume":"1147","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Pupi A, De Leon MJ (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease. Ann N Y Acad Sci 1147:180\u2013195","journal-title":"Ann N Y Acad Sci"},{"issue":"33","key":"3101_CR29","doi-asserted-by":"crossref","first-page":"31277","DOI":"10.1074\/jbc.M300763200","volume":"278","author":"D Mottet","year":"2003","unstructured":"Mottet D, Dumont V, Deccache Y, Demazy C, Ninane N, Raes M, Michiels C (2003) Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase\/Akt\/glycogen synthase kinase 3beta pathway in HepG2 cells. J Biol Chem 278(33):31277\u201331285","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"3101_CR30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(97)00688-1","volume":"411","author":"JR Munoz-Montano","year":"1997","unstructured":"Munoz-Montano JR, Moreno FJ, Avila J, Diaz-Nido J (1997) Lithium inhibits Alzheimer\u2019s disease-like tau protein phosphorylation in neurons. FEBS Lett 411(2\u20133):183\u2013188","journal-title":"FEBS Lett"},{"issue":"10","key":"3101_CR31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejcb.2009.05.003","volume":"88","author":"M Nowicki","year":"2009","unstructured":"Nowicki M, Kosacka J, Spanel-Borowski K, Borlak J (2009) Deferoxamine-induced neurite outgrowth and synapse formation in postnatal rat dorsal root ganglion (DRG) cell cultures. Eur J Cell Biol 88(10):551\u2013562","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"3101_CR32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-2952(66)90114-6","volume":"15","author":"G Peters","year":"1966","unstructured":"Peters G, Keberle H, Schmid K, Brunner H (1966) Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochem Pharmacol 15(1):93\u2013109","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"3101_CR33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbrc.2008.03.092","volume":"370","author":"ZH Qu","year":"2008","unstructured":"Qu ZH, Zhang XL, Tang TT, Dai KR (2008) Promotion of osteogenesis through beta-catenin signaling by desferrioxamine. Biochem Biophys Res Commun 370(2):332\u2013337","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3101_CR34","first-page":"209","volume":"19","author":"J Savory","year":"1998","unstructured":"Savory J, Huang Y, Wills MR, Herman MM (1998) Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer\u2019s disease. Neurotoxicology 19(2):209\u2013214","journal-title":"Neurotoxicology"},{"issue":"13","key":"3101_CR35","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1073\/pnas.95.13.7778","volume":"95","author":"H Schneider","year":"1998","unstructured":"Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO (1998) A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci USA 95(13):7778\u20137783","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"3101_CR36","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1460-9568.2009.06712.x","volume":"29","author":"D Schubert","year":"2009","unstructured":"Schubert D, Soucek T, Blouw B (2009) The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide. Eur J Neurosci 29(7):1323\u20131334","journal-title":"Eur J Neurosci"},{"issue":"38","key":"3101_CR37","doi-asserted-by":"crossref","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","volume":"269","author":"GL Semenza","year":"1994","unstructured":"Semenza GL, Roth PH, Fang HM, Wang GL (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269(38):23757\u201323763","journal-title":"J Biol Chem"},{"key":"3101_CR38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-5-7","volume":"5","author":"SS Shaftel","year":"2008","unstructured":"Shaftel SS, Griffin WS, O\u2019Banion MK (2008) The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 5:7","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3101_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0896-6273(03)00367-2","volume":"39","author":"T Soucek","year":"2003","unstructured":"Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39(1):43\u201356","journal-title":"Neuron"},{"issue":"1","key":"3101_CR40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2013is this type 3 diabetes? J Alzheimers Dis 7(1):63\u201380","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3101_CR41","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2353\/ajpath.2008.070904","volume":"172","author":"D Terwel","year":"2008","unstructured":"Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F (2008) Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 172(3):786\u2013798","journal-title":"Am J Pathol"},{"issue":"1","key":"3101_CR42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(02)00223-9","volume":"325","author":"C Thaung","year":"2002","unstructured":"Thaung C, Arnold K, Jackson IJ, Coffey PJ (2002) Presence of visual head tracking differentiates normal sighted from retinal degenerate mice. Neurosci Lett 325(1):21\u201324","journal-title":"Neurosci Lett"},{"issue":"3","key":"3101_CR43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","volume":"152","author":"RG Thorne","year":"2008","unstructured":"Thorne RG, Hanson LR, Ross TM, Tung D, Frey WH 2nd (2008) Delivery of interferon-beta to the monkey nervous system following intranasal administration. Neuroscience 152(3):785\u2013797","journal-title":"Neuroscience"},{"issue":"Pt 1","key":"3101_CR44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/0264-6021:3500307","volume":"350","author":"RD Thornton","year":"2000","unstructured":"Thornton RD, Lane P, Borghaei RC, Pease EA, Caro J, Mochan E (2000) Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem J 350(Pt 1):307\u2013312","journal-title":"Biochem J"},{"issue":"8","key":"3101_CR45","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.neuint.2010.03.025","volume":"56","author":"AM Tonin","year":"2010","unstructured":"Tonin AM, Grings M, Busanello EN, Moura AP, Ferreira GC, Viegas CM, Fernandes CG, Schuck PF, Wajner M (2010) Long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies induce oxidative stress in rat brain. Neurochem Int 56(8):930\u2013936","journal-title":"Neurochem Int"},{"issue":"1","key":"3101_CR46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(98)01090-4","volume":"436","author":"JZ Wang","year":"1998","unstructured":"Wang JZ, Wu Q, Smith A, Grundke-Iqbal I, Iqbal K (1998) Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett 436(1):28\u201334","journal-title":"FEBS Lett"},{"issue":"17","key":"3101_CR47","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1007\/s00018-007-7218-4","volume":"64","author":"X Zhu","year":"2007","unstructured":"Zhu X, Su B, Wang X, Smith MA, Perry G (2007) Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 64(17):2202\u20132210","journal-title":"Cell Mol Life Sci"}],"container-title":["Experimental Brain Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-012-3101-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00221-012-3101-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-012-3101-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T13:11:45Z","timestamp":1642165905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00221-012-3101-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,1]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["3101"],"URL":"https:\/\/doi.org\/10.1007\/s00221-012-3101-0","relation":{},"ISSN":["0014-4819","1432-1106"],"issn-type":[{"value":"0014-4819","type":"print"},{"value":"1432-1106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,1]]}}}